Venture Capital

AgileRL Raises Seed Round To Launch Arena RLOps Platform In The U.S.

By Amit Chowdhry ● Jan 8, 2026

AgileRL has raised a seed financing round backed by Fusion Fund and Flying Fish, with participation from existing investors Octopus Ventures and Counterview Capital, bringing the company’s total funding raised to $7.5 million.

Prudentia Sciences: $20 Million Series A Raised To Speed Life Sciences Deal Diligence

By Amit Chowdhry ● Jan 8, 2026

Prudentia Sciences announced it raised $20 million in Series A financing to expand its AI-native due diligence platform for life sciences dealmaking, aiming to help pharmaceutical companies, biotechs, and financial institutions evaluate therapeutic assets faster and with more rigor.

Luminate: $21 Million Series A Extension Closed To Scale At-Home Cancer Infusions And Patient-Led Delivery Technology

By Amit Chowdhry ● Jan 8, 2026

Luminate, a Galway, Ireland-based healthcare technology company focused on delivering cancer therapies in the home, has raised $21 million in an expanded Series A round, bringing total funding to more than $50 million. The round was co-led by ARTIS Ventures and Lachy Groom, with participation from Western Alliance Life Sciences and existing backers including 8VC, Y Combinator, Atlantic Bridge, Faber, SciFounders, and others. The company said the financing follows growing interest from health systems in its Lotus program for home-based cancer care.

Redgate Software Secures Growth Investment From Bregal Sagemount

By Amit Chowdhry ● Jan 8, 2026

Redgate Software announced it has received a strategic growth investment from Bregal Sagemount, a growth-focused private equity firm, in a transaction that will make Sagemount the majority shareholder of Redgate, pending regulatory approvals and customary closing conditions. Financial terms were not disclosed, and the companies said the deal is expected to close in late Q1 2026.

Adams Street Partners Closes $350 Million Debut Public CLO For Middle-Market Direct Lending Portfolio

By Amit Chowdhry ● Jan 8, 2026

Adams Street Partners’ private credit team has held the final close of a $350 million middle-market collateralized loan obligation, ASP PIF CLO I, LLC, marking the firm’s inaugural public CLO issuance. The firm said the deal expands its private credit financing toolkit and brings in third-party capital to support the continued growth of its direct lending platform.

Catalio Closes Structured Opportunities Fund II With Over $325 Million For Healthcare Structured Credit

By Amit Chowdhry ● Jan 8, 2026

Catalio Capital Management announced it has closed its second credit fund, Catalio Structured Opportunities Fund II, with more than $325 million in commitments across the fund and related co-investment vehicles, exceeding its fundraising target and signaling continued investor demand for non-dilutive financing options in healthcare.

ATG Emerges From Stealth With $15 Million To Build An AI-Based Financial Advisor

By Amit Chowdhry ● Jan 8, 2026

Autonomous Technologies Group (ATG) announced it has emerged from stealth as an AI research lab focused on building an advanced AI financial advisor, positioning its flagship product, Autonomous, as a personalized investment strategist that combines market data, portfolio theory, behavioral finance, and user context to guide investment decisions.

Poplar Therapeutics Launched With $50 Million Series A To Advance Anti-IgE Therapy for Multiple Atopic Conditions

By Amit Chowdhry ● Jan 8, 2026

Poplar Therapeutics has launched as a clinical-stage immunology company with a $50 million Series A financing to advance PHB-050, a next-generation anti-IgE antibody being developed for food allergy and other atopic conditions such as asthma and atopic dermatitis.

Adapture Renewables: $233 Million U.S. Bank Tax Equity Commitment Secured For Titanium Solar Projects

By Amit Chowdhry ● Jan 8, 2026

Adapture Renewables announced it has closed $233 million in tax equity financing commitments from U.S. Bank to support two solar projects in its Titanium portfolio, advancing the multi-site development toward construction completion and commercial operation.

IMVARIA Announces Strategic Investments For AI-Based Digital Biomarker Solutions

By Amit Chowdhry ● Jan 8, 2026

IMVARIA, a Berkeley, California-based health tech company developing AI-driven digital biomarker solutions, said it has secured strategic investments from new and existing investors to accelerate growth and expand its AI-powered diagnostic services.

Blackstone Buys Madison Dearborn’s Remaining Stake In AIR

By Amit Chowdhry ● Jan 8, 2026

Blackstone announced that funds managed by its private equity strategy for individual investors have acquired Madison Dearborn Partners’ remaining equity stake in AIR Control Concepts (AIR), increasing Blackstone’s ownership following its original investment in July 2024. Founder, President and CEO Brad Hobbs and his family will also invest alongside Blackstone, and the transaction makes Blackstone AIR’s sole institutional investor.

Corsera Health: $80 Million Series A Raised To Advance Cardiovascular Disease Prediction

By Amit Chowdhry ● Jan 8, 2026

Corsera Health announced it raised an oversubscribed $80 million Series A to advance its cardiovascular disease prediction-and-prevention strategy and to fund development of once-annual preventive RNAi medicines targeting the two primary drivers of atherosclerotic cardiovascular disease (ASCVD): elevated LDL cholesterol and high blood pressure. The round was co-led by Forbion and Population Health Partners, with participation from additional investors including Corsera co-founder and co-CEO John Maraganore, Ph.D. As part of the financing, Forbion general partner Marco Boorsma, Ph.D., will join Corsera’s board.

Nocion Therapeutics: $93 Million Series B Closed To Advance Taplucainium Toward Late-Stage Development In Chronic Cough

By Amit Chowdhry ● Jan 8, 2026

Nocion Therapeutics announced it has raised $23 million from existing investors in an extension of its Series B financing, bringing the total Series B proceeds to $93 million as the company advances taplucainium, its investigational inhaled therapy for refractory or unexplained chronic cough.

Soley Therapeutics: $200 Million Series C Closed To Advance Oncology Assets Into the Clinic

By Amit Chowdhry ● Jan 8, 2026

Soley Therapeutics has raised $200 million in Series C funding to move its cell stress-sensing platform and pipeline into clinical development, including IND-enabling work and trials for two first-in-class, internally discovered oncology programs. The company said proceeds will also support the advancement of non-oncology stress-reducing drug candidates targeting neurodegenerative disorders and metabolic diseases, as well as continued platform scale-up.

Varsity Healthcare Partners Makes Growth Investment In Trialbee

By Amit Chowdhry ● Jan 8, 2026

Varsity Healthcare Partners (VHP), a lower middle-market healthcare services private equity firm, said it has completed a strategic growth investment in Trialbee, a Sweden-headquartered, technology-enabled provider of patient recruitment services and analytics for clinical trials.

Adams Street Partners: $350 Million Raised For First Public CLO to Expand Private Credit Financing

By Amit Chowdhry ● Jan 8, 2026

Adams Street Partners has raised $350 million for its first publicly issued collateralized loan obligation, marking a new funding channel for the firm’s private credit platform.

Oasys: $4.6 Million Raised To Build An AI-Native Operating System For Behavioral Health

By Amit Chowdhry ● Jan 8, 2026

Oasys Health, which is known as an AI-native operating system for behavioral health, raised $4.6 million in funding to expand its platform that combines practice management, clinical decision support, and real-time physiological data from consumer wearables. The financing includes a $4 million seed round led by Pathlight Ventures with participation from Twine Ventures and Better Ventures, plus $600,000 in pre-seed funding from 1984 Ventures.

Spearmint Energy Lands Kyuden Equity Investment For Two 200 MWh ERCOT Battery Projects

By Amit Chowdhry ● Jan 8, 2026

Spearmint Energy closed an equity investment from Kyuden International Corporation to support Tierra Seca and Seven Flags, two 100 MW / 200 MWh battery energy storage systems (BESS) located in Del Rio and Laredo, Texas. The two projects add a combined 400 MWh of storage capacity to ERCOT, the Texas power grid.

Faropoint Secures $600 Million Acquisition Credit Facility For Industrial Value Fund IV

By Amit Chowdhry ● Jan 8, 2026

Faropoint has secured a $600 million acquisition credit facility to support its Industrial Value Fund IV, a vehicle focused on acquiring and upgrading last-mile urban logistics properties across key U.S. markets.

Vauban Infrastructure Partners Names Olivier Guerrini Investment Director

By Amit Chowdhry ● Jan 8, 2026

Vauban Infrastructure Partners said it has appointed Olivier Guerrini as Investment Director, effective January 2026, adding an energy transition executive with more than two decades of experience across utilities and independent power producers to the firm’s investment platform.

Lux: $1.5 Billion For Lux Ventures IX Closed

By Amit Chowdhry ● Jan 8, 2026

Lux, a venture capital firm focused on investing at the frontier of science and technology, announced the close of Lux Ventures IX, a $1.5 billion fund the firm described as its largest to date.

Spiro Medical: $67 Million Series Raised A To Develop Neuromodulation System For Asthma

By Amit Chowdhry ● Jan 8, 2026

Spiro Medical, a newly formed company focused on pulmonary neuromodulation for asthma, has closed a $67 million Series A equity financing to develop what it describes as a first-of-its-kind Pulmonary Neuromodulation System (PNM) for the treatment of asthma.

STRM.BIO: $8 Million Series Seed 2 Closed To Advance Non-Viral Gene Delivery For In Vivo Cell Engineering And Gene Therapy

By Amit Chowdhry ● Jan 8, 2026

STRM.BIO raised $8 million in a Series Seed 2 financing to advance its non-viral gene delivery platform for in vivo cell engineering and gene therapy. The round included funding from Recordati, with continued participation from Boehringer Ingelheim Venture Fund and Delos Capital, plus new backing from Blue Bay Capital Fund; the Seed 2 round remains open with plans to close by Q1 2026.

Swap: $100 Million Series C Raised To Expand Global Commerce Platform

By Amit Chowdhry ● Jan 8, 2026

Swap has raised a $100 million Series C round co-led by DST Global and ICONIQ, with ICONIQ increasing its stake after leading the company’s $40 million Series B six months earlier. The New York-based startup positions itself as a “commerce operating system,” evolving from a returns-focused product into a broader platform spanning cross-border commerce, tax, and demand planning.

Luxury Presence: $37 Million Secured To Launch Presence CRM

By Amit Chowdhry ● Jan 8, 2026

Luxury Presence said it has raised $37 million in new financing to accelerate the rollout of Presence CRM, a product the company describes as the first “AI relationship engine” designed to help real estate agents identify deal opportunities already embedded in their networks.

Cyera: $400 Million Series F At $9 Billion Valuation Raised As Enterprises Ramp Up AI Security

By Amit Chowdhry ● Jan 8, 2026

Cyera, an AI and data security company, has raised $400 million in a Series F funding round led by funds managed by Blackstone, pushing the company’s valuation to $9 billion and bringing total funding to more than $1.7 billion. The financing comes roughly six months after Cyera’s prior round and marks a valuation that the company says has tripled over the past year.

ViCentra Expands Series D To $98 Million To Scale Kaleido Insulin Patch Pump Commercialization

By Amit Chowdhry ● Jan 8, 2026

ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, said it has added $13 million in new capital to its Series D financing, bringing the total round to $98 million. The second close includes new investments from ROM Utrecht Region and a consortium of Dutch investors, including Venturing Tech, as well as increased backing from existing investor Innovation Industries.

Sibros Raises $9 Million in Growth Financing

By Amit Chowdhry ● Jan 8, 2026

Sibros has raised $9 million in a growth financing round, with Niterra Co., Ltd. participating in the investment as the software-defined vehicle (SDV) platform provider looks to expand product capabilities and scale commercialization.

TECregen Raises CHF 10 Million Seed Round, Names Dr. Bo Rode Hansen Chairman

By Amit Chowdhry ● Jan 8, 2026

Basel, Switzerland-based TECregen has raised CHF 10 million (approximately €10.7 million / $12.6 million) in seed financing to advance a new class of thymus-rejuvenating biologics aimed at restoring immune function by rejuvenating thymic epithelial cells (TECs). The round was led by the Boehringer Ingelheim Venture Fund (BIVF) and included participation from LifeSpan Vision Ventures, Carma Fund, EOS BioInnovation, High-Tech Gründerfonds (HTGF), the JFG Life Sciences Foundation of the University of Basel, and Zurich Cantonal Bank.

Enable Injections Announces $30 Million Sanofi Investment To Expand enFuse On-Body Injector Manufacturing

By Amit Chowdhry ● Jan 8, 2026

Enable Injections announced that Sanofi is making a $30 million investment in the Cincinnati-based drug delivery company to accelerate a manufacturing build-out, bolster supply chain capabilities, and support commercial growth for its enFuse on-body delivery system.